Viewing Study NCT05734105


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-01-01 @ 2:30 AM
Study NCT ID: NCT05734105
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
Sponsor: Deciphera Pharmaceuticals, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module